Featured Stories
Ropes & Gray Advises Basecamp Research on $140 Million Series C Financing
BOSTON, Massachusetts, Sept. 26 -- Ropes and Gray, a law firm, issued the following news:
* * *
Ropes & Gray Advises Basecamp Research on $140 Million Series C Financing
September 25, 2026
Ropes & Gray has advised Basecamp Research, a frontier AI company developing AI-designed medicines, on its oversubscribed $140 million Series C financing to train a new generation of EDEN models and advance a pipeline of AI-designed therapeutics towards clinical development.
Basecamp's ambition is to develop cures for diseases that remain incurable by designing medicines that reprogram the body to repair
... Show Full Article
BOSTON, Massachusetts, Sept. 26 -- Ropes and Gray, a law firm, issued the following news:
* * *
Ropes & Gray Advises Basecamp Research on $140 Million Series C Financing
September 25, 2026
Ropes & Gray has advised Basecamp Research, a frontier AI company developing AI-designed medicines, on its oversubscribed $140 million Series C financing to train a new generation of EDEN models and advance a pipeline of AI-designed therapeutics towards clinical development.
Basecamp's ambition is to develop cures for diseases that remain incurable by designing medicines that reprogram the body to repairitself. The company combines models trained on proprietary biological data with technology for writing DNA sequences into cells. Basecamp Research is applying EDEN, its biological foundation model, to in vivo cell therapy - reprogramming a patient's cells inside the body.
The oversubscribed round was led by S32, with participation from Menlo Ventures' Anthology Fund, Catalio Capital Management, European Tech Collective, Firebrand River Capital, Inception Fund, King Philanthropies, NATO Innovation Fund, NVIDIA, PostScriptum, Redalpine, The Rockefeller Foundation, Singular, Sovereign AI and True Ventures.
The firm has previously advised Basecamp on its Series B funding round and its investment from NVIDIA in its pre-Series C round.
The Ropes & Gray team was led by venture capital & emerging companies counsel David Dowling with support from life sciences licensing partner Hannah England, venture capital & emerging companies partner Rajarshi Banerjee, associates Velyana Borisova and Iain Fox, and trainee Madeleine Matthews. Additional support was provided by litigation & enforcement partners Brendan Hanifin and Lisa Kaltenbrunner, counsel Tom Jackson, and associates Vincenzo Volpe and Mez Azizi, tax partner Andy Howard and associate Luiza Galbraith, and capital markets partner William Michener and counsel Lisa Folkerth.
* * *
URL: Basecamp Research
* * *
Original text here: https://www.ropesgray.com/en/news-and-events/news/2026/09/ropes-gray-advises-basecamp-research-on-series-c-financing
[Category: BizLaw/Legal]
Ropes & Gray Advised Atavistik Bio in Roche Research Collaboration Worth Up to $2 Billion
BOSTON, Massachusetts, Sept. 26 -- Ropes and Gray, a law firm, issued the following news:
* * *
Ropes & Gray Advised Atavistik Bio in Roche Research Collaboration Worth up to $2 Billion
September 25, 2026
Ropes & Gray advised Atavistik Bio in a strategic research collaboration with Roche to discover and develop novel small molecule therapeutics against multiple targets for cardiovascular, renal, and metabolic (CVRM) diseases in a deal worth up to $2 billion that was announced on September 24.
The collaboration will leverage Atavistik Bio's proprietary AMPS drug discovery platform and experience
... Show Full Article
BOSTON, Massachusetts, Sept. 26 -- Ropes and Gray, a law firm, issued the following news:
* * *
Ropes & Gray Advised Atavistik Bio in Roche Research Collaboration Worth up to $2 Billion
September 25, 2026
Ropes & Gray advised Atavistik Bio in a strategic research collaboration with Roche to discover and develop novel small molecule therapeutics against multiple targets for cardiovascular, renal, and metabolic (CVRM) diseases in a deal worth up to $2 billion that was announced on September 24.
The collaboration will leverage Atavistik Bio's proprietary AMPS drug discovery platform and experiencein allosteric drug discovery to identify hidden pockets on disease-causing proteins, potentially allowing drugs to be developed against CVRM targets that have been challenging to modulate.
Under the agreement, Atavistik will receive an upfront payment of $70 million and is eligible to receive additional milestone payments up to $1.9 billion, plus tiered royalties on future net sales of approved treatments.
Atavistik will lead early discovery and research, while Roche will be responsible for further preclinical and clinical development, regulatory filings and commercialization.
The Ropes & Gray team included life sciences licensing partner Hannah England and associate Ian Nilsen.
* * *
URL: Atavistik Bio
* * *
Original text here: https://www.ropesgray.com/en/news-and-events/news/2026/09/ropes-gray-advised-atavistik-bio-in-roche-research-collaboration
[Category: BizLaw/Legal]
Morgan Lewis Advises Biolevate on Its Series A Funding Round
PHILADELPHIA, Pennsylvania, Sept. 26 -- Morgan Lewis, a law firm, issued the following news release:
* * *
Morgan Lewis Advises Biolevate on its Series A Funding Round
PARIS, September 25, 2026: Morgan Lewis advised Biolevate, a French AI company dedicated to life sciences, in connection with its Euros30 million (approximately $34.1 million) Series A funding round. The round was co-led by RAISE France, the investment vehicle of entrepreneur Aymar Henin, and Orange Ventures, with participation from the MSD Global Health Innovation Fund, Station F, and existing investor EQT Ventures.
This round
... Show Full Article
PHILADELPHIA, Pennsylvania, Sept. 26 -- Morgan Lewis, a law firm, issued the following news release:
* * *
Morgan Lewis Advises Biolevate on its Series A Funding Round
PARIS, September 25, 2026: Morgan Lewis advised Biolevate, a French AI company dedicated to life sciences, in connection with its Euros30 million (approximately $34.1 million) Series A funding round. The round was co-led by RAISE France, the investment vehicle of entrepreneur Aymar Henin, and Orange Ventures, with participation from the MSD Global Health Innovation Fund, Station F, and existing investor EQT Ventures.
This roundfollows the company's Euros6 million (approximately $6.8 million) seed round in November 2024, which was led by EQT Ventures.
Founded in Paris by a team of former Dataiku engineers and AI researchers, Biolevate develops an agentic AI platform spanning the full life sciences value chain, including research, clinical trials, health technology assessments, regulatory dossiers, and drug discovery and development.
The new funding will enable Biolevate to strengthen its product capabilities and accelerate its international expansion, including the opening of a Boston office.
The Morgan Lewis team advising Biolevate included partner Sebastien Pontillo, associate Thomas Maincent, and jurist Carole Ruggiu on the corporate aspects, and partner Mathilde Carle on IP matters.
For more information, read Biolevate's announcement (https://www.biolevate.com/news/series-a-2026).
* * *
URL: Biolevate
* * *
Original text here: https://www.morganlewis.com/news/2026/09/morgan-lewis-advises-biolevate-on-its-series-a-funding-round
[Category: BizLaw/Legal]
Littler: OSHA Releases New Guidance for Opioid Emergencies
SAN FRANCISCO, California, Sept. 26 -- Littler, a law firm, issued the following news:
* * *
OSHA Releases New Guidance for Opioid Emergencies
By Catherine Seidelman, Alka Ramchandani-Raj, Steve Biddle, and Peter Vassalo
September 25, 2026
With the opioid epidemic showing no signs of abating, OSHA released new guidance on September 24, 2026, as part of a government-wide effort to prioritize addiction treatment and recovery. The guidance is in the form of a Fact Sheet, "Opioid Overdose Rescue with Reversal Medications," designed to assist workplaces in recognizing the signs of an overdose and
... Show Full Article
SAN FRANCISCO, California, Sept. 26 -- Littler, a law firm, issued the following news:
* * *
OSHA Releases New Guidance for Opioid Emergencies
By Catherine Seidelman, Alka Ramchandani-Raj, Steve Biddle, and Peter Vassalo
September 25, 2026
With the opioid epidemic showing no signs of abating, OSHA released new guidance on September 24, 2026, as part of a government-wide effort to prioritize addiction treatment and recovery. The guidance is in the form of a Fact Sheet, "Opioid Overdose Rescue with Reversal Medications," designed to assist workplaces in recognizing the signs of an overdose andresponding swiftly.
OSHA's Fact Sheet provides several opioid overdose preparedness strategies, including:
* Keeping lifesaving, FDA-approved reversal medications - such as naloxone or nalmefene - on hand.
* Treating overdose kits like first aid kits by storing them in highly visible, easily accessible locations.
* Educating workers on how to recognize and react to symptoms of an overdose, such as slow or stopped breathing, blue lips or skin, pinpoint pupils, and unresponsiveness.
* Preparing to take immediate action in an emergency by training individuals on administering medication, safely positioning the individual, and providing care until first responders arrive.
Although the guidance recommends treating overdose kits like "first aid," it does not require an employer to implement these strategies. The guidance explicitly declines to create any new OSHA-specific requirements under existing provisions such as the Agency's Medical Services and First Aid standard or Recordkeeping regulation. Employers should, however, consider proactive steps such as maintaining a naloxone policy that addresses the right of employees to refuse to be administered the drug and making sure that existing emergency response plans adequately address such urgent situations. Employers in states with their own OSHA programs should consider whether state law imposes any additional requirements.
Employers interested in considering such strategies should consult workplace safety counsel.
* * *
Authors
Catherine Seidelman
Of Counsel
Chicago
cseidelman@littler.com
* * *
Alka Ramchandani-Raj
Shareholder
Walnut Creek
araj@littler.com
* * *
Steve Biddle
Shareholder
Phoenix
sbiddle@littler.com
* * *
Peter Vassalo
Senior Counsel
Washington, D.C.
pvassalo@littler.com
* * *
Original text here: https://www.littler.com/news-analysis/asap/osha-releases-new-guidance-opioid-emergencies
[Category: BizLaw/Legal]
Littler: Flexible Working - UK Government Confirms Next Steps on Employment Rights Act 2025 Reforms
SAN FRANCISCO, California, Sept. 26 -- Littler, a law firm, issued the following news:
* * *
Flexible Working: UK Government Confirms Next Steps on Employment Rights Act 2025 Reforms
The UK Government has published its response to the consultation launched on the ERA 2025 reforms to the right to request flexible working.
By Emily Bodger
September 25, 2026
The UK Government has now published its response to the consultation launched earlier this year on the Employment Rights Act 2025 ('ERA 2025') reforms to the right to request flexible working. Although further regulations are awaited, the
... Show Full Article
SAN FRANCISCO, California, Sept. 26 -- Littler, a law firm, issued the following news:
* * *
Flexible Working: UK Government Confirms Next Steps on Employment Rights Act 2025 Reforms
The UK Government has published its response to the consultation launched on the ERA 2025 reforms to the right to request flexible working.
By Emily Bodger
September 25, 2026
The UK Government has now published its response to the consultation launched earlier this year on the Employment Rights Act 2025 ('ERA 2025') reforms to the right to request flexible working. Although further regulations are awaited, thedetail of the changes is beginning to take shape.
Background
Flexible working has been the subject of employment law reform in recent years, including changes made in April 2024 (see our previous article here), which made the right to request flexible working a day one right for employees and introduced a requirement for employers to consult before refusing a request.
The ERA 2025 builds on that framework and introduces three key changes:
1. "Reasonableness" requirement - An employer will only be able to reject a statutory flexible working request on one of the eight statutory business grounds where it is "reasonable" to do so.
2. Notification - If an employer refuses a request, the notification must state the ground(s) for refusing the application and explain why the employer considers that it is reasonable to refuse the application on that ground.
3. New statutory process - Secondary legislation will set out steps that an employer must take in order to comply with its obligation to consult an employee before rejecting a request.
These reforms form part of the Government's commitment to improving access to flexible working and encouraging more constructive discussion between employers and employees. While this is not a complete rewrite of the laws, employers will be required to follow a more structured statutory process when dealing with requests.
Earlier this year, the Government launched a consultation focused on the proposed new mandatory consultation process for employers where they are considering rejecting a statutory flexible working request. The Government recently published its response to the consultation on September 15, 2026, which confirms its intention to proceed with the ERA 2025 reforms and provides further insight on what we can expect for the new consultation process.
Continue reading here (https://littler.co.uk/insights/flexible-working-government-confirms-next-steps-on-employment-rights-act-2025-reforms/).
* * *
Authors
Emily Bodger
Knowledge Lawyer
ebodger@littler.co.uk
* * *
Original text here: https://www.littler.com/news-analysis/asap/flexible-working-uk-government-confirms-next-steps-employment-rights-act-2025
[Category: BizLaw/Legal]
Jackson Walker: Robert Soza to Receive 2026 C. Lee Cusenbary Ethical Life and Leadership Award
AUSTIN, Texas, Sept. 26 -- Jackson Walker, a law firm, issued the following news:
* * *
Robert Soza to Receive 2026 C. Lee Cusenbary Ethical Life and Leadership Award
September 25, 2026
Jackson Walker partner Robert L. Soza Jr. has been named a recipient of the 2026 C. Lee Cusenbary Ethical Life and Leadership Award by the Association of Corporate Counsel's San Antonio Chapter and The Texas Lawbook.
The award honors one in-house lawyer or legal department and one private lawyer or law firm each year for exceptional ethical conduct and leadership in the practice of law.
Robert was nominated
... Show Full Article
AUSTIN, Texas, Sept. 26 -- Jackson Walker, a law firm, issued the following news:
* * *
Robert Soza to Receive 2026 C. Lee Cusenbary Ethical Life and Leadership Award
September 25, 2026
Jackson Walker partner Robert L. Soza Jr. has been named a recipient of the 2026 C. Lee Cusenbary Ethical Life and Leadership Award by the Association of Corporate Counsel's San Antonio Chapter and The Texas Lawbook.
The award honors one in-house lawyer or legal department and one private lawyer or law firm each year for exceptional ethical conduct and leadership in the practice of law.
Robert was nominatedby Julia W. Mann, managing partner of Jackson Walker's San Antonio office, who cited his professional excellence, principled leadership, sustained mentorship, and longstanding service to the community.
He will receive the honor alongside Vericast Deputy General Counsel Shelayne Clemmer at the 2026 San Antonio Corporate Counsel Awards on October 29.
To read the full The Texas Lawbook article, visit Vericast Deputy GC, Jackson Walker Partner Honored for Ethical Life, Leadership (https://texaslawbook.net/vericast-deputy-gc-jackson-walker-partner-honored-for-ethical-life-leadership/).
* * *
Meet Robert
Robert L. Soza Jr. is a seasoned attorney based in San Antonio with deep experience in international trade compliance and complex litigation. A licensed U.S. Customs Broker, he advises clients on FCPA, anti-corruption, anti-money laundering, export controls, trade sanctions, CFIUS, and U.S. Customs compliance--handling audits, enforcement counseling, voluntary disclosures, and government proceedings before agencies including the Departments of Commerce, State, and Treasury. He also brings significant first-chair trial and appellate experience in environmental, personal injury, and civil enforcement matters, having litigated cases across Texas, New Mexico, Colorado, Kansas, California, and New York.
Robert is a recognized leader in both his profession and his community. He received the President's Award from the San Antonio Bar Association in 2019, is a San Antonio Bar Foundation Fellow, and currently serves as President of the Board of Directors of the San Antonio Legal Services Association (SALSA). He has been named to Chambers USA, The Best Lawyers in America, Thomson Reuters' Super Lawyers, and Lawdragon's list of the 500 Leading Litigators in America.
* * *
Original text here: https://www.jw.com/news/soza-ethical-life-leadership-award/
[Category: BiLaw/Legal]
Hughes Hubbard: Michael Salzman Discusses AI-Related Risks and Accountability Facing Lawyers
NEW YORK, Sept. 26 -- Hughes Hubbard and Reed, a law firm, issued the following news:
* * *
September 25, 2026
Michael Salzman Discusses AI-Related Risks and Accountability Facing Lawyers
Explores the risks and responsibilities associated with lawyers' use of AI.
Highlights
* Salzman discusses risks associated with AI use by lawyers, including fabricated citations, incorrect legal analysis, false factual claims and privilege concerns around' general-purpose AI systems.
* Salzman explains how differing AI rules and guidance across jurisdictions present manageable challenges for legal practitioners.
-
Michael
... Show Full Article
NEW YORK, Sept. 26 -- Hughes Hubbard and Reed, a law firm, issued the following news:
* * *
September 25, 2026
Michael Salzman Discusses AI-Related Risks and Accountability Facing Lawyers
Explores the risks and responsibilities associated with lawyers' use of AI.
Highlights
* Salzman discusses risks associated with AI use by lawyers, including fabricated citations, incorrect legal analysis, false factual claims and privilege concerns around' general-purpose AI systems.
* Salzman explains how differing AI rules and guidance across jurisdictions present manageable challenges for legal practitioners.
-
MichaelSalzman - who is senior counsel at Hughes Hubbard, and previously spent four decades as a litigation partner and the firm's general counsel - discussed the legal profession's evolving approach to AI and the risks associated with its use with Newsweek.
The article examines how courts and professional bodies are developing guidance governing AI use as lawyers continue to face accountability for AI use in their work product, including instances where AI-generated materials have resulted in fabricated citations and other errors.
Salzman, who also serves as the chair of the New York City Bar's Professional Ethics Committee, explained the risks associated with AI use, including fabricated citations, incorrect legal analysis, false factual claims, and potential confidentiality and privilege concerns when lawyers use general-purpose AI systems.
Salzman also discussed how lawyers can navigate differing AI guidance across jurisdictions.
"The differences are not fundamental, and lawyers are used to dealing with differences in the laws and court rules in different places within the U.S.," Salzman said.
Over the past two years, the New York City Bar's Professional Ethics Committee has issued several opinions discussing the ethical obligations of lawyers when employing AI.
Read the article (https://www.newsweek.com/lawyers-face-patchwork-of-ai-rules-as-courts-punish-hallucinated-filings-12477505).
* * *
Featured Lawyers
Michael E. Salzman
Senior Counsel
Locations
New York
michael.salzman@hugheshubbard.com
212/837-6833
* * *
Original text here: https://www.hugheshubbard.com/news-insights/insights/michael-salzman-discusses-ai-related-risks-and-accountability-facing-lawyers
[Category: BizLaw/Legal]
